Dodatne informacije

• Lični podaci

• Datum rođenja: 28.10.1978.
• Mesto rođenja: Niš

• Obrazovanje

• Fakultet: Medicinski fakultet Univerzitet u NIšu
• Odsek / Grupa / Smer: Medicina
• Godina diplomiranja: 2004

• Spisak publikacija

• Knjige i udžbenici:

  1. Bjelaković, B (ur), Stamenković H, Živanović S, Stanković T, Lazarević D, Stanković S, Vučić J, Jovančić-Petković D, Ratković-Janković M, Vasić K, Radomirović D. (2025) „Osnovi Pedijatrije sa negom“ - Udžbenik za strukovne studije, Medicinski fakultet Univerziteta u Nišu, Niš, 228 strana, ISBN 978-86-6265-131-0.

• Radovi u časopisima sa IMPACT faktorom:

  1. Lazarevic D, Pistorio A, Palmisani E, Miettunen P, Ravelli A, Pilkington C,  еt al. The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Ann Rheum Dis 2013;72(5):683-693. doi: 10.1136/annrheumdis-2012-201483.  IF2 = 12,384; IF5 = 9,999 (M21a+)

  
  

  2. Miettunen P, Pistorio A, Palmisani E, Ravelli A, Silverman E, Oliveira S, Alessio M, Cuttica R, Mihaylova D, Espada G, Pasic S, Insalaco A, Ozen S, Porras O, Sztajnbok F, Lazarevic D, Martini A, Ruperto N. Therapeutic approaches for the treatment of renal disease in juvenile systemic lupus erythematosus: an international multicentre PRINTO study. Ann Rheum Dis 2013; 72(9):1503-1509. doi: 10.1136/annrheumdis-2012-201937.  IF2 = 12,384; IF5 = 9,999 (M21a+)

  
  

  3. Rosina S, Consolaro A, Dijkhuizen P, Pistorio A, Varnier GC, Bovis F....Lazarevic D. et al. Development and validation of a composite disease activity score for measurement of muscle and skin involvement in juvenile dermatomyositis. Rheumatology 2019;58(7):1196-1205. IF2= 7.580  IF5=7.089 (M21a)

  
  

  4.Magni-Manzoni S, Muratore V, Vojinović J, Pires Marafon D, D'Agostino MA, Naredo E; Lazarević D on behalf of Paediatric Rheumatology European Association (PReS) Imaging Working Party. Procedures for the content, conduct and format of EULAR/PReS paediatric musculoskeletal ultrasound courses. RMD Open. 2022 Jul;8(2):e002455.doi: 10.1136/rmdopen-2022-002455. PMID: 35798512; PMCID: PMC9263933. IF2=6.2 IF 5= 5.7 (M21a) *studijski rad (Lazarevic D. u okviru the Paediatric Rheumatology European Association (PReS) Imaging Working Party)

  
  

  5. Milenković J, Vojinović J, Debeljak M, Toplak N, Lazarević D, Avčin T, et al. Distribution of MEFV gene mutations and R202Q polymorphism in the Serbian population and their influence on oxidative stress and clinical manifestations of inflammation. Pediatr Rheumatol 2016; 14(1):39. doi: 10.1186/s12969-016-0097-1.  IF2 = 2,673; IF5 = 2,840 (M21)

  
  

  6. Varnier GC, Rosina S, Ferrari C, Pistorio A, Consolaro A....., Lazarevic D et al. Development and testing of a hybrid measure of muscle strengt in juvenile dermatomyositis for use in routine care. Аrthritis Care Res (Hoboken) 2018; 70(9):1312-1319. doi: 10.1002/acr.23491. IF2 = 4,530; IF5 = 4,439 (M21)

  
  

  7. Stamenkovic HM, Lazarevic D, Stankovic T, Vojinovic J, Lekic B, Marinkovic A, Bosic M. Linear IgA dermatosis of the childhood-Report of an amoxicillin-induced case. Dermatol Ther 2019; e13173. https://doi.org/10.1111/dth.13173   IF2 = 3,858 IF5= 3,674  (M21)

  
  

  8.Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Tererii MT, Sakamoto AP...... Lazarevic D. Differences sustained between diffuse and limited forms of juvenile systemic sclerosis in expanded international cohort. www.juvenile-scleroderma.com.  Arthritis Care Res (Hoboken). 2022 Oct;74(10):1575-1584 doi: 10.1002/acr.24609. IF2=4.7 IF5=5.0 (M21)

  
  

  9.Zečević M, Živanović D, Adamović T, Lazarevic D, Marjanović V, Jovanović Z, Lilić J. Profile of Children with Child Abuse from Serbia. Indian Pediatr. 2022 Sep 15;59(9):707-709. IF2= 3.839 IF5=2.8 (M21)

  
  

  10. Susic G, Vojinovic J, Vijatov Djuric G, Stevanovic D,  Lazarevic D, Djurovic N et al. The Serbian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR). Rheumatol Int 2018; 38 (Suppl 1):S347–S354. doi: 10.1007/s00296-018-3972-x. IF2 = 2,200; IF5 = 2,025 (M22)

  
  

  11. Bašić J, Vojinović J, Jevtović-Stoimenov T, Despotović M, Cvetković T, Sušić G, Lazarević D, Milošević V, Cvetković M, Pavlović D. Vitamin D receptor gene polymorphism influences lipid profile in patients with juvenile idiopathic arthritis. Clin Rheumatol 2019; 38(1):117-124.  IF2=3,650 IF5 =3,348 (M22)

  
  

  12. Bašić J, Vojinović J, Jevtović-Stoimenov T, Despotović M, Cvetković T, Lazarević D. et al. The association of CAT-262C/T polymorphism with catalase activity and treatment response in juvenile idiopathic arthritis  Rheumatol Int 2019;39(3):551-559. IF2= 3,580  IF5= 3,247 (M22).

  
  

  13. Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Terreri MT, Sakamoto AP, Stanevicha V, Anton J, Feldman BM, Sztajnbok F, Khubchandani R, Alexeeva E, Katsicas M, Sawhney S, Smith V, Appenzeller S, Avcin T, Kostik M, Lehman T, Marrani E, Schonenberg-Meinema D, Sifuentes-Giraldo WA, Vasquez-Canizares N, Janarthanan M, Moll M, Nemcova D, Patwardhan A, Santos MJ, Battagliotti C, Berntson L, Bica B, Brunner J, Cimaz R, Costa-Reis P, Eleftheriou D, Harel L, Horneff G, Johnson SR, Kaiser D, Kallinich T, Lazarevic D, et al. Gender differences in juvenile systemic sclerosis patients: Results from the international juvenile scleroderma inception cohort. J Scleroderma Relat Disord. 2023 Jun;8(2):120-130. doi: 10.1177/23971983221143244. Epub 2022 Dec 19. IF2=2.0 IF5=2.5 (M22)

  
  

  14.Lazarević D, Stamenković H, Stanković T, Đorđević S, Novaković D, Zečević M, Sušić G, Živković V. Impact of Biologic Therapy, School Success, Parent's Education and Socioeconomic Status on Transition Readiness in Adolescents with Juvenile Idiopathic Arthritis and Their Parents. Indian Pediatr. 2025 Sep 15. doi: 10.1007/s13312-025-00188-1. Epub ahead of print. PMID: 40952425. IF2=1.5 IF5=1.7 (M22)

  
  

  15.Djordjevic SA, Ostojic P, Radunovic G, Mujovic N, Kovacevic S, Novakovic D, Lazarevic D, Petrovic H, Bijelic M, Dimkic-Tomic T, Dimkic-Milenkovic A, Milenkovic V, Susic G. Prevalence and clinical risk factors for methotrexate intolerance in patients with juvenile idiopathic arthritis. ARP Rheumatol. 2025 Oct-Dec;4(4):285-293. English. PMID: 41480884. IF2= 1.4 IF 5=1.4 (M22) 

  
  

  16. Lazarević D, Nikolić I, Ratković-Janković M, Vojinović J. Outcome of juvenile idiopathic arthritis (JIA) associated uveitis in two diseases subtypes. Arch Rheumatol 2017; 32(1):26-31. doi:10.5606/ArchRheumatol.2017.6060. IF2 = 0,312; IF5 = 0,339 (M23)

  
  

  17.Lazarević D, Đorđević S, Novaković D, Zečević M. and Sušić G. Transition readiness in adolescents with juvenile idiopathic arthritis and their parents: Our single-center experience. Arch Rheumatol 2021; Dec 24;37(3):411-416 DOI: 10.46497/ArchRheumatol.2022.9219. IF2=1.472 IF5=1.161 (M23)

  
  

   

  
  

   

  
  

   

  
  

   

• Radovi u ostalim časopisima:

  1. Radovic J, Lazarevic D, Nikolic I, Vojinovic J. Effect of Alfacalcidol on Oxidative Stress and Disease Activity in JIA Patients. Ann Paediatr Rheum 2012; 1(2): 126-132.

  
  

  2. Jovanović N, Lazarević D, Vasić K, Stamenković H. Kawasaki disease: a single center experiece. Med. čas. 2025; 59(2): 64-69.

  
  

  3. Vojinović J, Lazarević D, Pejčić Lj, Ratković-Janković M, Nikolić I, Jakovljević M.   Аdvances in ultrasound application in juvenile idiopathic arthritis. Paediatr Cro 2017;61 (Supl 1):1-5.

  
  

  4. Lazarević D, Ratković-Janković M, Jakovljević M, Vojinović J. Dugotrajna efikasnost i bezbednost primene adalimumaba u lečenju juvenilnog idiopatskog artritisa (JIA) sa uveitisom Long term efficacy and safety of adalimumab in Juvenile Idiopathic Arthritis (JIA) associated uveitis. Acta Medica Medianae 2021 doi:10.5633/amm.2021.0304.

  
  

  5. Zečević M, Marjanović M, Janković G, Djerić D, Jovanović Z, Marjanović V, Lilić J, Mancić D, Lazarević D. The impact of the covid-19 pandemic on pediatric appendicitis management and outcomes. FU Med Biol Vol 2021. 23, No 2: 31−34.

  
  

  6. Vojinović J, Stanković T, Lazarević D, Ratković-Janković M, Nikolić I. Cijepljenje imunokompromitirane djece. Paediatr Cro 2019;63 (Supl 1):225-228.

  
  

  7. Manojlović M, Lazarević D, Ratković Janković M, Stanković S, Golubović E, Vojinović J. Immunoglobulin G (IGg4) related disease and granulomatosis with polyangiitis (GPA) in childhood: a case report of new overlap syndrome Acta Medica Medianae 2023; 62(3): 103 -108. doi: 10.5633/amm.2023.0315

  
  

  8. Ratković-Janković M, Pejčić Lj, Ilić D, Janković S, Živanović S, Nikolić I, Lazarević D, Miljković D. Nutcraker syndrome in children- a single center experience. Acta Medica Medianne 2023; 62(4):110-116.  doi: 10.5633/amm.2023.0414

  
  

  9.Stanković T, Harfman−Mihajlović K, Lazarević D, Vasić K, Stamenković H. Clinical features of 22q11.2 deletion syndrome: a literature review and case series reports. Acta Medica Medianae 2024;63(3): 127−132.  

  
  

  10. Lazarević D. Poliartikularni juvenilni idiopatski artritis: prevencija hroničnih oštećenja zglobova. Prev Ped 2017; 3(1-2): 21 -24.

  
  

  11. Lazarević D, Zečević M. Oligoartikularni juvenilni idiopatski artritis: pravovremena dijagnoza i terapija u cilju prevencije hroničnih oštećenja zglobova. Prev Ped 2024;10(2):56-59. 

  
  

  12. Vojinović J., Sušić G., Lazarević D. Diferencijalna dijagnoza artritisa dečijeg uzrasta. Predavanje po pozivu štampano u celosti. Acta rheumatologica Belgradensia 2010; Vol 40 Suppl 2: 63-67.

  
  

  13. Sušić G, Gordana Vijatov-Đurić, Lazarević D. Dijagnoza i diferencijalna dijagnoza juvenilnog idiopatskog artritisa. Predavanje po pozivu štampano u celosti. Acta rheumatologica Belgradensia 2016; Vol 46 Suppl 1: 131-134.

  
  

  14. Lazarević D, Milenković J, Vojinović J. Predavanje po pozivu štampano u celosti. Autoinflamatorne bolesti. Balneoclimactologia 2018; Vol 42 (1): 105-117.

• Radovi na naučnim skupovima međunarodnog značaja:

   

  
  
  
  
  1. 
     

     Vojinovic J, Basic J, Susic G, Lazarevic D, Damjanov N. Impact of FokI VDR and TNFalpha-308 Polymorphism on Disease Severity and Long-Term Outcome in JIA Patients on Anti-TNF Treatment. Arthritis Rheumatism 2012; 64 (10): S495. https://acrabstracts.org/abstract/impact-of-foki-vdr-and-tnfalpha-308-polymorphism-on-disease-severity-and-long-term-outcome-in-jia-patients-on-anti-tnf-treatment/

     
     2. Vojinovic J, Lazarevic D, Dimic M. Vitamin D and bone mineral density in health and disease. Is vitamin D analogue treatment option in JIA? Clin Exp Rheum 2011; 29(2): 436. https://www.clinexprheumatol.org/abstract.asp?a=4958
     

     3. Lazarevic D, Golubovic E, Vojinovic J, Stankovic T. Severe atypical Henoch-Schonlein Purpura with elements of Microscopic Polyangitis. Clin Exp Rheum 2011; 29(2): 455. https://www.clinexprheumatol.org/abstract.asp?a=4958

     
     

     4. Lazarevic D, Radovic J, Debeljak M, Toplak N, Avcin T, Vojinovic J. Influence of MEFV Gene Mutations and R202Q Polymorphism on Inflammatory Clinical Manifestations and Oxidative Stress. Ann Rheum Dis 2015; 74(Suppl 2): 841-842. DOI:10.1136/annrheumdis-2015-eular.5298.http://dx.doi.org/10.1136/annrheumdis-2015-eular.5298

     
     

     5. Lazarevic D, Vojinovic J. Autologous stem-cell transplantation (ASCT) as treatmet option in a child with severe systemic sclerosis. Ann Rheum Dis 2014; 73(Suppl2):1094. DOI:10.1136/annrheumdis-2014-eular.4710.http://dx.doi.org/10.1136/annrheumdis-2014-eular.4710

     
     

     6. Vojinovic J, Jeftovic T, Lazarevic D, Susic G. Long term outcome and FoKI VDR polimorphism in JIA patients on anti-TNF treatment. Ann Rheum Dis 2013; 72(Suppl 3):739. DOI: 10.1136/annrheumdis-2013-eular.2191

     
     

     7. Lazarevic D, Vojinovic J. Immuglobuline G4 (IGG4) Deposit Disease And Orbital Pseudotumor аs First Manifestations оf Wegener's Granulomatosis (WG) In Child. Ann RheumDis2012;71(Suppl3):681.DOI:10.1136/annrheumdis-2012eular.749.http://dx.doi.org/10.1136/annrheumdis-2012-eular.749

     
     

     8. Ferrari C, Consolaro A, Varnier G, Rao AP, Lazarevic D, Demirkaya E, et al. Comparison of construct validity of two functional ability measures in children with juvenile dermatomyositis. Ann Rheum Dis 2012;71(Suppl3): 427-428.DOI:10.1136/annrheumdis-2012-eular.2793http://dx.doi.org/10.1136/annrheumdis-2012-eular.2793

     
     

     9. Lazarevic D, Vojinovic J, Dimic A. Vitamin D Levels аnd Bone Mineral Density Values In Juvenile Idiopathic Arthritis (JIA). Ann Rheum Dis 2010;69(Suppl 3):709. https://scientific.sparxip.net/archiveeular/?searchfor=lazarevic&c=a&view=1&item=2010AB0816

     
     

     10. Lazarevic D, Vojinovic J, Susic G, et Basic J. Inflence of clinical and genetic characteristics on ability to achieve and maintain remission in JA patients on etanercept treatment. Pediatr Rheumatol Online J 2014; 12(Suppl 1): P48. DOI: 10.1186/1546-0096-12-S1-P48.

     
     

     11. Vojinovic J, Radovic J, Lazarevic D, Jeftić-Stoimenov T, Pavlovic D. Oxidative stress in children with episodic fever of unknown origin. Pediatr Rheumatol Online J 2013; 11(Suppl 2): P215. DOI: 10.1186/1546-0096-11-S2-P215.

     
     

     12. Lazarevic D, Vojinovic J. Outcome of macrophage activation syndrom (MAS) in systemic juveile idiopatic arthritis (SJIA) biologic trated patient. Pediatr Rheumatol Online J 2013; 11(Suppl 2): P53. DOI: 10.1186/1546-0096-11-S2-P53.

     
     

     13. Lazarevic D, Pistorio A, Miettunen P, Ravelli A, Malattia C, Clarissa Pilkington et al. The PRINTO provisional definition of remission in juvenile dermatomyositis. Pediatr Rheumatol Online J 2011; 9(Suppl 1): P194. DOI:10.1186/1546-0096-9-S1-P194.

     
     

     14. Vojinovic J, Susic G, Lazarevic D, Basic J, Nikolic I, Damjanov N. Influence of TNFα-308 and T676 TNF-RII polymorphism on response to etanercept and posibility to discotinue treatment. Pediatr Rheumatol Online J 2011; 9(Suppl 1): P277. DOI: 10.1186/1546-0096-9-S1-P277.

     
     

     15. Varnier GC, Consolaro A, Malattia C, Rao AP, Madeo A, Demirkaya E, Lazarevic D, Civino A, Martini A, Raveli A. Development and initial validation of a new fuctional ability tool for juvenile dermatomyositis. Pediatr Rheumatol Online J 2011;9 (Suppl 1): P61. DOI: 10.1186/1546-0096-9-S1-P61.

     
     

     16. Lazarević D, Vojinović J, Sušić G, Damjanov N, Bašić J. DNase I levels and disease outcome in JIA patients treated with etanercept. Pediatr Rheumatol Online J 2011;9(Suppl 1): P171.DOI:10.1186/1546-0096-9-S1-P171.

     
     

     17. Lazarević D, Vojinović J, Sušić G, Bašić J. Influence of FOKI vitamin D receptor (VDR) and TNFα-308 tumor necrosis factor gene polymphism on long term disease outcome in juvenile idiopathic arthritis (JIA). Pediatric Rheumatology 2017, 15(Suppl 1):148-149. P269. DOI 10.1186/s12969-017-0142-8.

     
     

     18. Lazarević D, Vojinović J. New pathogenic familiar heterozygous NLRP3 gene missence variant associated with reccurent pericardatis clinical presentation. Pediatric Rheumatology2017,15(Suppl2):P185.DOI10.1186/s12969-017-0186-9. https://ard.bmj.com/content/78/Suppl_2/1969.1

     
     

     19. Lazarević D, Vojinović J, Sušić G, Bašić J, Milenković J. Contribution of vitamin D receptor FOKI gene polymorphism on disease severity and long-term disease outcome in juvenile idiopathic arthritis (JIA). XVII Mediterranean Congress of Rheumatology. Clinical Experimental Rheum, Genoa, Italia 2018, 36(1): S 79.

     
     

     20. Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Torok K, Stanevicha V,...... Lazarevic D. Update from the juvenile scleroderma inception cohort. Arthritis and RheumatologyACR/ARHPAnnualMeeting2018;70(59):1557-1558. https://acrabstracts.org/abstract/update-from-the-juvenile-scleroderma-inception-cohort/

     
     

     21. Lazarevic D, Vojinovic J. Tocilizumab as treatment option for achieving sustained remission in a child with takayasu arteritis. Pediatric Rheumatology 2018,16(Suppl2):39-40. P051.https://doi.org/10.1186/s12969-018-0265-6

     
     

     22. Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Torok K, Stanevicha V, ......Lazarevic D. Update from the juvenile scleroderma inception cohort. www.juvenile-scleroderma.com. Pediatric Rheumatology 2018, 16(Suppl 2):141-142 P270. https://doi.org/10.1186/s12969-018-0265-6

     
     

     23. Lazarevic D, Vojinovic J. AB1006 The clinical spectrum of two heterozygous mutations in the MVK gene confirming hyperimmunoglobulin D syndrome. Ann Rheum Dis 2019: 78(Suppl 2):1969.1-1969. DOI: 10.1136/annrheumdis-2019-eular.7899.

     
     

     24. Rosina S, Varnier GC, Pistorio A, Consolaro A, Pilkington C, Maillard S, ... Lazarevic D. FRI0571 Measurement performance of reduced versions of muscle strength tools in juvenile dermatomyositis. Ann Rheum Dis 2019, 78(suppl 2):981.1-981. doi: 10.1136/annrheumdis-2019-eular.2228

     
     

     25. Foeldvari I, B. Hinrichs, Torok K, Santos MJ, Kasapcopur O, Adrovic A, ......Lazarevic D.  I Under Detection of Interstitial Lung Disease in Juvenile Systemic Sclerosis (jSSc) Utilizing Pulmonary Function Tests: Results from the Juvenile Scleroderma Inception Cohort. Arthritis and Rheumatology ACR/ARP Annual Meeting 2019: P 796. https://acrabstracts.org/abstract/under-detection-of-interstitial-lung-disease-in-juvenile-systemic-sclerosis-jssc-utilizing-pulmonary-function-tests-results-from-the-juvenile-scleroderma-inception-cohort/

     
     

     26. Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Torok K, Stanevicha V, ......Lazarevic D. Is the Presentation and Severity Different of the Juvenile Difuse and Limited Subtype Systemic Sclerosis? Results of Juvenile Scleroderma Inception Cohort. Arthritis and Rheumatology ACR/ARP Annual Meeting 2019: P 795. https://acrabstracts.org/abstract/is-the-presentation-and-severity-different-of-the-juvenile-diffuse-and-limited-subtype-systemic-sclerosis-results-of-juvenile-scleroderma-inception-cohort/

     
     

     27. Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Torok K, Stanevicha V, ......Lazarevic D. AB0967 Is there a difference in presentation of female and male patients with juvenile systemic scleroderma. an update from the juvenile systemic scleroderma inception cohort. www.juvenile-scleroderma.com. Ann Rheum Dis 2019:78(Suppl 2):1949-1950. DOI:10.1136/annrheumdis-2019-eular.2776

     
     

     28. Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Torok K, Stanevicha V, ......Lazarevic D. SAT0479 Update from the juvenile scleroderma inception cohort. www.juvenile-scleroderma.com. Ann Rheum Dis 2019: 78(Suppl 2):1328. DOI: 10.1136/annrheumdis-2019-eular.2550

     
     

     29. Foeldvari I, B. Hinrichs, Torok K, Santos MJ, Kasapcopur O, Adrovic A, ......Lazarevic D. FRI0454 Under detection of interstitial lung disease in juvenile systemic sclerosis (jssc) utilizing pulmonary function tests. results from the juvenile scleroderma inception cohort. Ann Rheum Dis 2020; 79(Suppl 1):824.1-824. DOI:10.1136/annrheumdis-2020-eular.1788.

     
     

     30. Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Torok K, Terrerri MT.....Lazarevic D. THU0499 Is there a different presentation of juvenile systemic diffuse and limited subset? data from the juvenile scleroderma inception cohort. www.juvenile-scleorderma.com. Ann Rheum Dis 2020; 79(Suppl1):487-488.DOI: 10.1136/annrheumdis-2020-eular.1667.http://dx.doi.org/10.1136/annrheumdis-2020-eular.1667

     
     

     31. Foeldvari I, B. Hinrichs, Torok K, Santos MJ, Kasapcopur O, Adrovic A, .....Lazarevic D. Under Detection of Interstitial Lung Disease in Juvenile Systemic Sclerosis (jSSc) Utilizing Pulmonary Function Tests. Results from the Juvenile Scleroderma Inception Cohort. Arthritis and Rheumatology 2020; 72 (Suppl 10) https://acrabstracts.org/abstract/under-detection-of-interstitial-lung-disease-in-juvenile-systemic-sclerosis-jssc-utilizing-pulmonary-function-tests-results-from-the-juvenile-scleroderma-inception-cohort-2/

     
     

     32. Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Torok A, Terreri MT.......Lazarevic D Is there a different presentation of juvenile systemic diffuse and limited subset? data from the juvenile scleroderma inception cohort. www.juvenile-scleorderma.com.  Pediatric Rheumatology 2020, 18(Suppl 2):44; P210. Proceedings of the 26th European Paediatric Rheumatology Congress: part 2 (biomedcentral.com)

     
     

     33. Lazarevic D, Jakovljevic M, Vojinovic. Long term treatment with adalimumab in Juvenile Idiopathic Arthritis associated uveitis - our experience. Pediatric Rheumatology 2020, 18(Suppl 2): 74; P271

     
     

     https://ped-rheum.biomedcentral.com/track/pdf/10.1186/s12969-020-00470-5.pdf

     
     

     34. Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Torok K, Terrerri MT.....Lazarevic D. POS1304 Juvenile systemic sclerosis (jssc) patients with overlap characteristics do not have mild disease. results from the jssc inception cohort. www.juvenilescleroderma.com. Ann Rheum Dis 2021:80(suppl 1):934.1-934. DOI: 10.1136/annrheumdis-2021-eular.1613.

     
     

      35. Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Torok K, Terrerri MT.....Lazarevic D. POS0079 Patients with juvenile systemic sclerosis have a distinct pattern of organ involvement. results from the juvenile systemic sclerosis inception cohort. www.juvenile-scleroderma.com. Ann Rheum Dis 2021, 80 (suppl 1): 247.2-247. DOI: 10.1136/annrheumdis-2021-eular.799

     
     

     36. Lazarevic D, Đorđević S, Novaković D, Sušić G. Transition Readiness in adolescents with Juvenile idiopathic arthritis (JIA) and their parents-our expirience. Pediatric Rheumatology 2021, 19(Suppl 1): 110; P 170

     
     

     https://ped-rheum.biomedcentral.com/track/pdf/10.1186/s12969-021-00632-z.pdf

     
     

     37. Foeldevari I, …Lazarevic D, еt al. Male juvenile systemic sclerosis patients have more severe disease: results from the international juvenile scleroderma inception cohort. www.juvenile-scleroderma.com. Pediatric Rheumatology 2021, 19(Suppl 1): 160-161; P271. https://ped-rheum.biomedcentral.com/track/pdf/10.1186/s12969-021-00632-z.pdf

     
     

     38. Foeldevari I, …Lazarevic D, et al. Patients with juvenile systemic sclerosis have a distinct pattern of organ involvement. results from the juvenile systemic sclerosis inception cohort. Pediatric Rheumatology 2021, 19(Suppl 1): 110 161-162; P 273. https://ped-rheum.biomedcentral.com/track/pdf/10.1186/s12969-021-00632-z.pdf

     
     

     39. Foeldvari I, Klotche J, Kasapcour O, Adrovic A, Torok K…. Lazarevic D, et al. Male Juvenile Systemic Sclerosis Patients Have More Severe Disease: Results from the International Juvenile Scleroderma Inception Cohort. Arthritis Rheumatol 2021; 73 (Suppl 10). https://acrabstracts.org/abstract/male-juvenile-systemic-sclerosis-patients-have-more-severe-disease-results-from-the-international-juvenile-scleroderma-inception-cohort/

     
     

     40. Foeldvari I, Klotche J, Kasapcour O, Adrovic A, Torok K…Lazarevic D, et al. Patients with Juvenile Systemic Sclerosis Have a Distinct Pattern of Organ Involvement: Results from the Juvenile Systemic Sclerosis Inception Cohort. Arthritis Rheumatol 2021; 73 (Suppl10).https://acrabstracts.org/abstract/patients-with-juvenile-systemic-sclerosis-have-a-distinct-0-from-the-juvenile-systemic-sclerosis--inception-cohort/

     
     

     41. Foeldvari I, Klotche J, Carreira P, Kasapcour O, Torok K…. Lazarevic D. Diffuse juvenile systemic sclerosis patients show distinct organ involvement and have more severe disease in the largest jssc cohort of the world. results from the the juvenile scleroderma inception cohort. Ann Rheum Dis2022;81(Suppl1):315-316. https://congress.eular.org/myUploadData/files/euroab_2022_book_final.pdf

     
     

     42. Foeldvari I, Klotche J, Carreira P, Kasapcour O, Torok K…. Lazarevic D. Clinical characteristics of juvenile onset systemic sclerosis patients from the juvenile scleroderma inception cohort compared to adult age juvenile-onset patients from eustar. are these differences suggesting risk for mortality? Ann Rheum Dis 2022; 81 (Suppl 1):1729-1730.  https://congress.eular.org/myUploadData/files/euroab_2022_book_final.pdf

     
     

     43. Foeldvari I, Klotche J, Carreira P, Torok K, Kasapcour O…. Lazarevic D. Diffuse juvenile systemic sclerosis patients show distinct organ involvement, antibody pattern and have significantly more severe disease in the largest jssc cohort of the world. results from the juvenile scleroderma inception cohort Ann Rheum Dis 2023; 82 (Suppl 1):289-290.        https://congress.eular.org/myUploadData/files/eular_2023_abstract_book.pdf

     
     

     44. Foeldvari I, Klotche J, Torok K, Kasapcour O…. Lazarevic D. Is decreased body mass index -2 z score or less correlating with an organ involvement pattern? results from the juvenile scleroderma inception cohort. Ann Rheum Dis 2023; 82 (Suppl 1):1938.        https://congress.eular.org/myUploadData/files/eular_2023_abstract_book.pdf

     
     

     45. Lazarevic D, Mallatia C, Rebollo Gimenez AI, Rossi Semerano L, Sozeri B, Tsinti M et al. Applicability of standardized ultrasound examination to estimate disease activity in combination with JADAS and inflammation markers in JIA patients – the DAISY study design.AnnRheumDis2023;82(Suppl1):1944-1945.  https://congress.eular.org/myUploadData/files/eular_2023_abstract_book.pdf

     
     

     46. Lazarevic D, Vojinovic J. The clinical presentation of Hyperimmunoglobulin D syndrome: 2O^th BIENNIAL MEETING OF THE EUROPEAN SOCIETY FOR IMMUNODEFICEINCIES:341.PD201.https://esidmeeting.org/wpcontent/uploads/sites/31/2024/02/ESID-2022-E-Poster-Book_14-September_FINAL.pdf

     
     

     47. Foeldvari I, Klotche J, Torok K, Kasapcour O, Adrovic A, …. Lazarevic D. Differences in clinical presentation between juvenile systemic sclerosis patients with diffuse and limited subtype. results from the juvenile scleroderma inception cohort. Ann Rheum Dis 2024;83(Suppl1):1162.https://congress.eular.org/myUploadData/files/euroab_2024_with_index.pdf

     
     

     48. Foeldvari I, Klotche J, Torok K, Kasapcour O, Adrovic A, …. Lazarevic D. Is there a difference in the number of involved organ systems between juvenile diffuse and limited subtype systemic sclerosis patients? Ann Rheum Dis 2024; 83 (Suppl 1):2226. https://congress.eular.org/myUploadData/files/euroab_2024_with_index.pdf

     
     

     49. Foeldvari I, Klotche J, Torok K, Kasapcour O, Adrovic A, …. Lazarevic D. Presence of nailfold capillary changes correlates with more severe organ involvement in juvenile systemic scleroderma. results of the juvenile scleroderma inception cohort. Ann Rheum Dis2024;83(Suppl1):1165.https://congress.eular.org/myUploadData/files/euroab_2024_with_index.pdf

     
     

     50. Foeldvari I, Klotche J, Torok K, Kasapcopur O, Adrović A,…. Lazarevic D. Anticentromere antibodies are occurring only in 6% of juvenile systemic sclerosis patients but correlate with more severe pulmonary involvement.  Ann Rheum Dis 2025:1107-1108.

     
     

     51. Foeldvari I, Klotche J, Torok K, Kasapcopur O, Adrović A ... Lazarevic D. Age of onset effect on the clinical manifestations of patients with juvenile systemic sclerosis. Ann Rheum Dis 2025:1208-1209.

     
     

     52. Foeldvari I, Klotche J, Torok K, Terren MT, Johnson SR …, Lazarevic D. Is anti Scl 70 positivity associatd with more severe disease in juvenile systemic scleroderma. Ann Rheum Dis 2025:2281-2282.

     
     

     53. Lazarevic D, Vojinovic J, Malattia C, Rossi-Semerano L, Sozeri B, Tsinti M. et al. Internal consistency and interrater reliability in musculoskeletal ultrasound in children. Pediatric Rheumatology 2022, 20(Suppl 2):121; P204. Proceedings of the European PaediatricRheumatologyCongres.https://pedrheum.biomedcentral.com/counter/pdf/10.1186/s12969-022-00729-z.pdf

     
     

     54. Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Torok K…… Lazarevic D. Diffuse juvenile systemic sclerosis patients show distinct organ involvement and have more severe disease in the largest JSSC cohort of the world. Results from the the juvenile scleroderma inception cohort. Pediatric Rheumatology 2022, 20(Suppl 2):183; P328. ProceedingsoftheEuropeanPaediatricRheumatologyCongreshttps://pedrheum.biomedcentral.com/counter/pdf/10.1186/s12969-022-00729-z.pdf

     
     

     55. Foeldvari I, Klotsche J, Carreira P, Kasapcopur O, Adrovic A, Torok K…… Lazarevic D. Clinical characteristics of juvenile onset systemic sclerosis patients from the juvenile scleroderma inception cohort compared to adult age juvenile-onset patients from eustar. are these differences suggesting risk for mortality? Pediatric Rheumatology 2022, 20(Suppl 2):184-185; P331. Proceedings of the European Paediatric Rheumatology Congreshttps://pedrheum.biomedcentral.com/counter/pdf/10.1186/s12969-022-00729-z.pdf

     
     

     56. Lazarevic D, Vucic J, Milosevic-Anđelkovic Z, Stamenkovic H, Stankovic T, Vojinovic J. Clinical and laboratory presentation of Neonatal Lupus Erythematosus (NLE) - case report. Pediatric Rheumatology 2022, 20(Suppl 2):265; PU03. Proceedings of the EuropeanPaediatricRheumatologyCongreshttps://pedrheum.biomedcentral.com/counter/pdf/10.1186/s12969-022-00729-z.pdf

     
     

     57. Lazarevic D, Kessel C, Föll D, Vojinovic J. Serum biomarkers for prediction of disease activity status in Juvenile Idiopathic Arthritis (JIA) – single center experience. Pediatric Rheumatology 2023, 21(Suppl 2):269-270; P412. Proceedings of the European Paediatric Rheumatology Congres https://perheum.biomedcentral.com/counter/pdf/10.1186/s12969-023-00879-8.pdf

     
     

     58. Lazarevic D, Vojinovic J, Đorđević S, Novaković D, Zečević M, Sušić G. Transition readiness in adolescents with Juvenile Idiopathic Arthritis (JIA) and their parents – two center experience. Pediatric Rheumatology 2023, 21(Suppl 2):270; P413. Proceedings of theEuropeanPaediatricRheumatologyCongreshttps://perheum.biomedcentral.com/counter/pdf/10.1186/s12969-023-00879-8.pdf-

     
     

     59. Foeldvari I, Klotsche J, Torok K, Kasapcopur O, Adrovic A…. Lazarevic D. Anti-topoisomerase positivity is not associated with baseline organ severity in juvenile systemic sclerosis. Pediatric Rheumatology 2023, 21(Suppl 2):138-139; P137. ProceedingsEuropeanPaediatricRheumatologyCongreshttps://perheum.biomedcentral.com/counter/pdf/10.1186/s12969-023-00879-8.pdf-

     
     

     60. Foeldvari I, Klotsche J, Torok K, Kasapcopur O, Adrovic A…. Lazarevic D. Difuse juvenile systemic sclerosis patients show distinct organ involvement, antibody pattern and have more severe disease in the largest JSSC cohort of the world, results from the juvenile scleroderma inception cohort. Pediatric Rheumatology 2023, 21(Suppl 2):137;P135.ProceedingsoftheEuropeanPaediatricRheumatologyCongreshttps://perheum.biomedcentral.com/counter/pdf/10.1186/s12969-023-00879-8.pdf-

     
     

     61. Lazarević D, Clinical presentation of bruton agammaglobulinemia P64. IPIC 5th Edition: International Primary Immunodefficiencies Congress 2022.

     
     

     62. Lazarević D, Zečević M, Vojinović J. Hidradenitis suppurativa: when its first misdiagnosed in adolescent with poor treatment adherence. Pediatric Rheumatology 2024, 22 (2):112;P083. Proceedings of the European Paediatric Rheumatology Congres.

     
     

     https://ped-rheum.biomedcentral.com/counter/pdf/10.1186/s12969-024-01004-z.pdf

     
     

     63. Djordjević S, Sušić G, Lazarević D, Novakovic D, Kovacević S, Ostojić P. The prevalence and risk factors for methotrexate intolerance in patients with Juvenile idiopathic arthritis Pediatric Rheumatology 2024, 22 (2):15; P 205. Proceedings of the EuropeanPaediatricRheumatologyCongreshttps://pedrheum.biomedcentral.com/counter/pdf/10.1186/s12969-024-01005-y.pdf

     
     

     64. Foeldvari I…., Lazarević D, et al. There is no difference in major organ involvement and antibody pattern between diffuse and limited subtype Juvenile onset systemic scleroderma patients. Paediatric Rheumatology 2024, 22 (2):82; P 345. Proceedings of theEuropeanPaediatricRheumatologyCongresshttps://pedrheum.biomedcentral.com/counter/pdf/10.1186/s12969-024-01005-y.pdf

     
     

     65. Foeldvari I…., Lazarević D, et al. Presence of nailfold capillary changes correlates with more severe organ involvement in juvenile systemic scleroderma. Results of the Juvenile scleroderma inception cohort. Pediatric Rheumatology 2024, 22 (2):85; P 351. Proceedings of the European Paediatric Rheumatology Congres. https://ped-rheum.biomedcentral.com/counter/pdf/10.1186/s12969-024-01005-y.pdf

     
     

     66. Foeldvari I…., Lazarević D, et al. Is there a diference in the number of involved organ systems between Juvenile difuse and limited subtype systemic sclerosis patients? Pediatric Rheumatology 2024, 22 (2):85; P 352. Proceedings of the European Paediatric RheumatologyCongreshttps://pedrheum.biomedcentral.com/counter/pdf/10.1186/s12969-024-01005-y.pdf

     
     

     67. Lazarevic D, Sawhney S, Rossi L, Pistorio A, Maronese N, Vojinovic J, Malattia C. A comparison between the OMERACT and CARRA synovitis ultrasound scoring systems in juvenile idiopathic arthritis: results of a multicentre reliability study. Pediatric Rheumatology2025 23(Suppl2):47.PT069.chromeextension://efaidnbmnnnibpcajpcglclefindmkaj/https://pedheum.biomedcentral.com/counter/pdf/10.1186/s12969-025-01138-8.pdf

     
     

     68. Foeldevari I, ... Lazarevic D, et al. A clear pattern of clinical presentation in juvenile systemic scleroderma is associated with interstitial lung disease. Pediatric Rheumatology 2025 23(Suppl2):5354.PT082.chromextension://efaidnbmnnnibpcajpcglclefindmkaj/https://pedheum.biomedcentral.com/counter/pdf/10.1186/s12969-025-01138-8.pdf

     
     

     69. Foeldevari I, ... Lazarevic D, et al. Age of onset effect on the clinical manifestations of patients with juvenile systemic sclerosis. Pediatric Rheumatology 2025 23(Suppl 2):125. P165.chromeextension://efaidnbmnnnibpcajpcglclefindmkaj/https://pedheum.biomedcentral.com/counter/pdf/10.1186/s12969-025-01138-8.pdf

     
     

     70. Foeldevari I, ...Lazarevic D, et al. Anticentromere antibodies are occurring only in 6% of juvenile systemic sclerosis patients but correlate with more severe pulmonary involvement.PediatricRheumatology2025 23(Suppl2):126.P168.chromextension://efaidnbmnnnibpcajpcglclefindmkaj/https://pedheum.biomedcentral.com/counter/pdf/10.1186/s12969-025-01138-8.pdf

     
     

     71. Foeldevari I, ...Lazarevic D, et al. Is gastroesophageal reflux a risk for interstitial lung disease in juvenile systemic sclerosis? Pediatric Rheumatology 2025 23(Suppl 2):126. P169.chromextension://efaidnbmnnnibpcajpcglclefindmkaj/https://pedheum.biomedcentral.com/counter/pdf/10.1186/s12969-025-01138-8.pdf

     
     

     72. Foeldevari I, ...Lazarevic D et al. Is anti-SCL70 positivity associated with a more severe disease in juvenile systemic scleroderma? Pediatric Rheumatology 2025 23(Suppl 2):127. P170.chromextension://efaidnbmnnnibpcajpcglclefindmkaj/https://pedheum.biomedcentral.com/counter/pdf/10.1186/s12969-025-01138-8.pdf

     
     

     73. Djordjevic S, Vitomirac M, Cazic M, Petrovic H, Lazarevic D, Novakovic D, Susic G. Cytological analysis of synovial fluid in patients with Juvenile idiopathic arthritis. PediatricRheumatology2025 23(Suppl2):159.P241.chrome3xtension://efaidnbmnnnibpcajpcglclefindmkaj/https://pedheum.biomedcentral.com/counter/pdf/10.1186/s12969-025-01138-8.pdf

     
     

     74. Lazarevic D, Vojinovic J, Stamenkovic H, Stankovic T, Zecevic M. Diagnostic difficulties in child with primary hypertrophic osteoarthropathy (PHO). Pediatric Rheumatology2025 23(Suppl2):237.PU46.chromeextension://efaidnbmnnnibpcajpcglclefindmkaj/https://pedheum.biomedcentral.com/counter/pdf/10.1186/s12969-025-01138-8.pdf

     
     

     75. Foeldvari I…., Lazarevic D, et al. Diffuse Juvenile Systemic Sclerosis Patients Show Distinct Organ Involvement, Antibody Pattern and Have More Severe Disease in the Largest jSSc Cohort of the World. Results from the Juvenile Scleroderma Inception Cohort [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9) ACR Meeting Abstracts. https://acrabstracts.org/abstract/diusejuvenile-systemic-sclerosis-patients-show-distinct-organ-involvement-antibody-pattern-andhave-more-severe-disease-in-the-largest-jssc-cohort-of-the-world-results-from-the-juvenilescleroder/

     
     

     76. Foeldvari I…., Lazarevic D, et al. Diffuse Juvenile Systemic Sclerosis Patients Show Distinct Organ Involvement and Have More Severe Disease in the Largest jSSc Cohort of the World. Results from the the Juvenile Scleroderma Inception Cohort [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). ACR Meeting Abstracts https://acrabstracts.org/abstract/diuse-juvenile-systemic-sclerosis-patients-showdistinct-organ-involvement-and-have-more-severe-disease-in-the-largest-jssc-cohort-of-theworld-results-from-the-the-juvenile-scleroderma-inception-c/

     
     

     77. Foeldvari I, … Lazarevic D, et al. There Is No Difference in Major Organ Involvement Antiantibody Pattern Between Difuse and Limited Subtype juvenile Onset systemic Scleroderma Patients [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). ACR Meeting Abstracts-https://acrabstracts.org/abstract/there-is-no-dierence-in-major-organinvolvement-andantibody-pattern-between-diuse-and-limited-subtypejuvenile-onsetsystemicscleroderma-patients/

     
     

     78. Foeldvari I…., Lazarevic D, et al. A clear pattern of clinical presentation injuvenile systemic scleroderma is associated with interstitial lung disease [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/a-clear-pattern-of-clinical-presentation-in-juvenile-systemic-scleroderma-is-associated-with-interstitial-lung-disease/.

     
     

     79. Lazarević D, Vasić K, Stamenković H, Stanković T, Vojinović J. Diverse clinical presentation of the new pathogenic heterozygous missense mutation of the gene encoding NLRP3 in one family. P486. 21st Biennial Meeting of the European Society for Immunodeficiencies (ESID), Marseille, France 2024.

     
     
  
  
  
  
  
  

  80. Lazarevic D. Pediatric arthritis approach. 3. Internacionalni kongres i 38. Pedijatrijski hibridni kurs Aktuelnosti u Pedijatriji, Meksiko 2022. https://jcinnovation.com/congresopediatria/registro.php

  
  

  81. Lazarević D. Documentation of US images and report of US findings. PReS Pediatric Musculoskeletal course-basic level, Goteburg, Sweden 2024. https://www.pres.eu/pres2024/ultrasound-course.html

  
  

  82. Lazarevic D, Damgaard M.  PedMSUS incorporation into daily practice with cases. PReS Pediatric Musculoskeletal course-basic level, Goteburg, Sweden 2024. https://www.pres.eu/pres2024/ultrasound-course.html

  
  

  83. Lazarevic D, Magni-Manzoni S. Sonoanatomy, standardised scanning and basic pathological findings of the child’s wrist and hand and live demo PReS Pediatric Musculoskeletal course-basic level, Helsinki, Finland 2025. https://www.pres.eu/pres2025/msus-course.html

  
  

  84. Lazarevic D, Rossi-Semerano L, Lanni S. PedMSUS in daily practice – interesting cases. PReS Pediatric Musculoskeletal course-basic level, Helsinki, Finland 2025. https://www.pres.eu/pres2025/msus-course.html

  
  
  
  
  
  

   

  
  
  
  
   
  
  
   
• Radovi na domaćim naučnim skupovima:
  
  
  1. 
     

     Lazarević D. Poliartikularni artritis - Prevencija hroničnih oštećenja zglobova. Prev Ped 2017; Vol 3 (1-2):21-24 .

     
     
  
  
  2. Lazarević D. Biološki lekovi u dečjim reumatskim bolestima. XXXV republičko savetovanje o dečjim reumatskim bolestima. Udruženje reumatologa Srbije i Institut za reumatologiju Beograd 2012.
  
  
  3. Lazarević D. Bol i otok zglobova kod dece - od simptoma do dijagnoze. XXXVI republičko savetovanje o dečjim reumatskim bolestima. Udruženje reumatologa Srbije i Institut za reumatologiju Beograd 2013.
  
  
  4. Lazarević D. Sistemske bolesti vezivnog tkiva kod dece. XXXVII republičko savetovanje o dečjim reumatskim bolestima. Udruženje reumatologa Srbije i Institut za reumatologiju Beograd 2015.
  
  
  5. Lazarević D. Dijagnostičke i terapijske dileme u reumatskim bolestima dece. XXXVIII republičko savetovanje o dečjim reumatskim bolestima. Udruženje reumatologa Srbije i Institut za reumatologiju Beograd 2016.
  
  
  6. Lazarević D. Lečenje reumatskih bolesti kod dece-problemi i nedoumice. XXXIX republičko savetovanje o dečjim reumatskim bolestima. Udruženje reumatologa Srbije i Institut za reumatologiju Beograd 2017.
  
  
  7. Lazarević D. Biološki lekovi u dečjim reumatskim bolestima. XXXX republičko savetovanje o dečjim reumatskim bolestima. Udruženje reumatologa Srbije i Institut za reumatologiju Beograd 2018.
  
  
  8. Lazarević D. Klinička prezentacija i diferencijalna dijagnoza juvenilnog idiopatskog artritisa. Pedijatrijska sekcija Srpskog lekarskog društva, Kragujevac 2018.
  
  
  9. Lazarević D. Klinička prezentacija i diferencijalna dijagnoza juvenilnog idiopatskog artritisa. 9. kongres Udruženje Preventive Pedijatrije UPPS, Soko Banja 2022:37.
  
  
  10. Lazarević D. Simpozijum autoinflamatorne bolesti, HIDS. 42. republičko savetovanje o dečjim reumatskim bolestima. Udruženje reumatologa Srbije i Institut za reumatologiju Beograd 2022.
  
  
  11. Lazarević D. Autoinflamatorne bolesti. II Simpozijum Udruženja za preventivnu pedijatriju Srbije, Divčibare 2022 Zbornik:28-31.
  
  
  12. Lazarević D. Takayasu arteritis prikaz slucaja. III Simpozij3um Udruženja za preventivnu pedijatriju Srbije, Kuršumlijska Banja  2023 Zbornik:24-25.
  
  
  13. Lazarević D. Algoritam u dijagnostici juvenilnog idiopatskog artritisa. X Nacionalni kongres Udruženja za preventivnu pedijatriju Srbije, Kopaonik 2023 Zbornik:96.
  
  
  14. Lazarević D. Kawasakijeva bolest. XI Nacionalni kongres Udruženja za preventivnu pedijatriju Srbije, Kopaonik 2024:65-66.
  
  
  15. Lazarević D. Hidradenitis suppurativa. IV Simpozijum Udruženja za preventivnu pedijatriju Srbije, Niš  2024 Zbornik:37.
  
  
  16. Lazarević D. Recidivna febrilna stanja - kada posumnjati na dijagnozu. Pedijatrijski dani Nis 2024 Zbornik:27-28.
  
  
  17. Lazarević D. Targeted therapy for IEIs, our expirience; Ciljana terapija kod pacijenata sa urođenim poremećajima imunološkog sistema: nase iskustvo. Srpska grupa za primarne imunodeficijencije, Beograd 2025 Zbornik:30-31.
  
  
  18. Lazarević D. Kada posumnjati na periodične febrilne sindrome kod dece. XII Nacionalni kongres Udruženja za preventivnu pedijatriju Srbije, Zlatibor 2025: 47.
  
  
  19. Lazarević D. Diferencijalna dijagnoza zglobnih tegoba kod dece i pregled lokomotornog sistema. Prvi kongres Značaj i uloga Pedijatara Primarne Zdravstvene zaštite, Sokobanja 2025 Zbornik:16.
  
  
  20. Lazarević D. Izazov tranzicije kod hroničnih zapaljenskih bolesti. Pedijatrijski dani,  2025 Zbornik: 29.
  
  
  21. Lazarević D Karakteristike Kawasaki sindroma kod dece. V Simpozijum o retkim i autoimunski posredovanim bolestima Udruženja za preventivnu pedijatriju, Niš 2025.  
  
  
  22. Vojinović  J, Sušić G, Bašić J, Lazarević D, Damjanov N. Uticaj genetskog polimorfizma za TNF alpha 308 i T676G TNF-RII na ishod lečenja i mogućnost prekid anti-TNF lečenja u juvenilnom idiopatskom artritisu. Acta rheumatologica Belgradensia 2010; Vol 40 Suppl 2: 113.
  
  
  23. Vojinović  J, Lazarević D, Sušić G, Bašić -Milošević J. Uticaj FokI polimorfizma gena za vitamin D receptor (VDR) na ishod bolesti u juvenilnom idiopatskom artritisu (JIA). Acta rheumatologica Belgradensia 2013; Vol 43 Suppl 1: 97.
  
  
  24. Radović J, Lazarević D, Debeljak M, Vojinović J. Zastupljenost R202Q polimorfizma i mutacija MEFV gena i njihov uticaj na kliničke znake inflamacije u populaciji zdravih osoba u Srbiji. Acta rheumatologica Belgradensia 2014; Vol 44 Suppl 1: 60.
  
  
  25. Lazarevic D, Vojinovic J. Terapijska efikasnost i bezbednost lečenja uveitisa. Acta rheumatologica Belgradensia 2015; Vol 45 Suppl 1: 58-59.
  
  
  26. Lazarević D, Vojinović J. Efikasnost terapije Metotrexatom u obolelih od JIA, 41. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2008: 50-51.
  
  
  27. Lazarević D, Vojinović J, Sušić G, Bašić-Milošević J. Polimorfizam FokI gena za vitamin D receptor (VDR) u juvenilnom idiopatskom artritisu (JIA). 45. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2013:93.
  
  
  28. Milenković J, Lazarević D, Debeljak M, Toplak N, Avčin T, Vojinović J. Uticaj mutacija i R202Q polimorfizma MEFV gena na kliničke znake inflamacije i oksidativni stres. 46. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2015:48-49.
  
  
  29. Lazarević D, Vojinović J. Lečenje uveitisa u juvenilnom idiopatskom artritisu (JIA)-naša iskustva. 46. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2015:51.
  
  
  30. Milojević V, Lazarević D, Subotić G. Hipernatremija-terapijski algoritmi. 46. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2015:109.
  
  
  31. Nikolić I, Živanović S, Zivanović SJ, Kitić D, Ratković-Janković M , Lazarević D, Pejčić Lj. Upotreba biljnih preparata u lečenju respiratornih infekcija dece. 47. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2016:69.
  
  
  32. Ratković-Janković M, Miljković P, Golubović E, Stanković S, Vučić J, Cvetković V, Kostić M, Nikolić I, Lazarević D, Paunović-Stojiljković M, Pančić D, Ristić T, Milojević D, Milošević-Anđelković Z. Ultrazvučno ispitivanje anatomskih karakteristika bubrega kod dece. 47. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2016:115-116.
  
  
  33. Kostić M, Golubović E, Vojinović J, Miljković P, Ratković-Janković M, Lazarević D, Stajić S, Trajković A. Vezikoureteralni refluks  i benigni hipermobilni sindrom. 47. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2016:116.
  
  
  34. Lazarević D, Vojinović J. Takayasu arteritis: dijagnostički i terapijski izazov. 48 Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2017:48-49.
  
  
  35. Jakovljević M, Lazarević D, Vojinović J. Inkompletna Kawasakijeva bolest-prikaz slučaja. 48 Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2017:49-50.
  
  
  36. Lazarević D. Poliartikularni artritis - Prevencija hroničnih oštećenja zglobova. Četvrtii godišnji kongres Udruženja za preventivnu pedijatriju Srbije (UPPS) sa međunarodnim učešćem, Zbornik apstrakata 2017:72.
  
  
  37. Lazarević D, Vojinovic J. Efikasnost primene tocilizumaba za postizanje dugotrajne remisije kod adolescentkinje sa Takayasu arteritisom. Acta rheumatologica Belgradensia 2018; Vol 48 Suppl 1: 55.
  
  
  38. Lazarević D, Vojinovic J, Stamenković H, Stanković T, Ratković-Janković M, Nikolić I. Komplikacije varičele kod deteta na imunosupresivnoj terapiji. 49. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2019: 107.
  
  
  39. Stamenković H, Lazarević D, Vojinovic J, Lekić B, Bosić M, Marinković A. Linearna IgA dermatoza-prikaz slučaja. 49. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2019: 109.
  
  
  40. Ratković-Janković M, Golubović E, Pejčić Lj, Miljković P, Nakev I, Nikolić I, Lazarević D. Akutno oštećenje bubrega - dijagnostičke dileme. 49. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2019: 17-18.
  
  
  41. Nikolić I, Ratković-Janković M, Lazarević D, Pejčić Lj, Živanović S. Kriza svesti ili nesto drugo. 49. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2019: 40.
  
  
  42. Lazarević D, Vojinović J, Đorđević S, Novaković D, Sušić G. Spremnost adolescenata obolelih od juvenilnog idiopatskog artritisa (JIA) i njihovih roditelja za proces tranzicije od pedijatrijskog ka adultnom reumatologu. 50. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2021:45.
  
  
  43. Lazarević D, Vučić J, Milošević Anđelković Ž, Stamenković H, Stanković T, Vojinović J. Klinička I laboratorijska prezentacija neonatalnog lupusa (prikaz slučaja). Acta rheumatologica Belgradensia 2022, Vol 52 Suppl 1:143.
  
  
  44. Zečević M, Živanović D, Adamović T, Lazarević D, Marjanović V, Jovanović Z, Lilić J. Kako prepoznati zlostavljano dete? Demografske karakteristike i klinička prezentacija. 51. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2023:61.
  
  
  45. Lazarević D, Živković V, Vojinović J, Đorđević S, Novaković D, Sušić G. Procena spremnosti adolescenata obolelih od juvenilnog idiopatskog artritisa (JIA) i njihovih roditelja za proces tranzicije od pedijatrijskog ka adultnom reumatologu. Acta rheumatologica Belgradensia 2023:75.
  
  
  46. Kocić H, Tiodorović, Lazarević D, Vojinović J. Generalizovana psorijaza u najmlađem uzrastu kao dijagnostički izazov. Peti kongres Udruženja za preventivnu pedijatriju Srbije (UPPS) sa međunarodnim učešćem, Zbornik apstrakata 2018:44.
  
  
  47. Manojlović M, Lazarević D, Ratković-Janković M, Vojinović J. Fenotipska ekspresija porodice sa neobičnom NLRP3 mutacijom. 4. Kongres Pedijatara Srbije 2022:71-72.
  
  
  48. Vučić J, Lazarević D, Milošević Anđelković Ž, Stanković S, Jovančić Petković D, Stamenković H, Stanković T. Neonatalni lupus -prikaz slučaja 4. Kongres Pedijatara Srbije 2022:121.
  
  
  49. Marković A, Lazarević D, Stanković T, Vasić K, Vučić J, Milošević Anđelković Ž, Vojinović J, Stamenković H. Kada treba posumnjati na DiGeogeov sindrom-serija slučajeva. IV Simpozium o retkim bolestima Udruženja za preventivnu pedijatriju Srbije, Divčibare Knjiga apstrakta 2024:56-57.
  
  
  50. Cvetković J, Lazarević D, Stanković T,  Pejčić-Đorđević T, Jovančić-Petković D, Vojinović J, Stamenković H. Da li je tromboza krvnog suda posledica komplikacije  purpure henoch – schoinlein ili postojanja urođene trombofilije?  prikaz slučaja. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2024:71.
  
  
  51. Marković A, Lazarević D, Stanković T, Vasić K, Vučić J, Milošević Anđelković Ž, Vojinović J, Stamenković H. Kada treba posumnjati na Digeorgeov sindrom u neonatalnom periodu. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2024:58.
  
  
  52. Stošić Lj, Jovančić Petković D, Ratković Janković M, Vojinović J, Lazarević D, Mitrović I, Bogićević V, Nakev I, Mihajlović D, Miljković D, Lutovac V. Imunska trombocitopenijska purpura kao inicijalna manifestacija sistemskog eritemskog lupusa kod bliskih srodnika − prikaz slučaja. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2024:47-48.
  
  
  53. Marković A, Lazarević D, Stamenković H. Akutni hemoragični edem u detinjstvu (AHEI) -prikaz slučaja. XII Nacionalni kongres Udruženja za preventivnu pedijatriju Srbije (UPPS) sa međunarodnim učešćem, Zbornik apstrakata 2025:56.
  
  
  54. Mihajlović D, Stanković T, Lazarević D, Stošić Lj, Ratković Janković M.Nutcraker sindrom u sklopu Ehlers-Danlosovog sindroma. Prvi kongres Značaj i uloga Pedijatara Primarne Zdravstvene zaštite, Sokobanja 2025:27.
  
  
  55. Stošić Ljubica, Lazarević D, Vojinović J, Mihajlović D, Sahiti E. Zglobne tegobe kao inicijalna prezentacija sistemskog eritemskog lupusa kod dece-prikaz slučaja. Prvi kongres Značaj i uloga Pedijatara Primarne Zdravstvene zaštite, Sokobanja 2025:26.
  
  
  56. Marković A, Lazarević D, Stamenković H. Akutni hemoragični edem u detinjstvu (AHEI) -prikaz slučaja. Prvi kongres Značaj i uloga Pedijatara Primarne Zdravstvene zaštite, Sokobanja 2025:30.
  
  
  57. Stošić Lj, Vojinović J,  Stamenković H, Stanković T, Mihajlović D, Miljković D,  Lutovac V, Vukčević I, Petrović I, Marković A, Lazarević D. Inicijalna klinička prezentacija sistemskog eritemskog lupusa kod dece. Pedijatrijski dani Niš 2025: 47-48.
  
  
  58. Stanojević A, Stamenković H, Vojinović J, Lazarević D.  Apsces mozga kao komplikacija hronične granulomatozne bolesti: očekivani tok bolesti ili posledica loše komplijanse? Pedijatrijski dani Niš 2025: 48-49.
  
  
  59. Mihajlović D, Ratković Janković M, Stanković T, Lazarević D, Stanković S, Vučić J, Stošić Lj, Miljković D, Videnović J, Nikolić V, Andrejević M, Stanković A,  Ilić K. Nutcracker sindrom kao vaskularna manifestacija Ehlers - Danlosovog sindroma? − prikaz slučaja. Pedijatrijski dani Niš 2025: 51.
  
  
  60. Stanković T, Vojinović J, Jovančić J, Stanković S, Stošić Lj, Jakovljević M, Ilić J, Lazarević D, Stamenković H, Mitrović I, Miljković D, Mihajlović D.  Genetička dijagnostika retkih poremećaja; dvogodišnje iskustvo Klinike za pedijatriju UKC Nis. Pedijatrijski dani Niš 2025: 27-28.
  
  
  61. Lazarevic D, Vojinovic J, Sindrom aktivacije makrofaga u sistemskom JIA –prikaz slučaja. Acta rheumatologica Belgradensia 2008, Vol 38 Suppl 1:128.
  
  
  62.  Lazarević D, Golubović E, Vojinović E, Stanković T. Atipična purpura Hoenoch-Schonlein - prikaz slučaja. Acta rheumatologica Belgradensia 2009, Vol 39 Suppl 1:68-69.
  
  
  63. Vojinović J, Lazarević D, Dimić M, Vitamin D i vrednosti koštane gustine kod pacijenata obolelih od Juvenilnog idiopatskog artritisa, Acta rheumatologica Belgradensia 2010, Vol 40 Suppl 2 :121.
  
  
  64. Lazarević D, Vojinović J, Sušić G, Damjanov N, Bašić J. Nivo dezoksiribonukleaze I i ishod pacijenata obolelih od JIA lečenih etanerceptom. Acta rheumatologica Belgradensia 2011, Vol 41 Suppl 1: 96-97.
  
  
  65. Milojević D,Ćirić V, Milošević Z, Vučić J, Petrović Z, Perović Lj, Paunović M, Lazarević D. Izbegnuto utapanje - prikaz slučaja, 41. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2008: 167.
  
  
  66. Miljković P, Lazarević D, Nikolić I, Milojević D, Vučić  J, Milošević Z, Djordjević D, Stanković S, Stanković T, Živić S, Golubović E. Akutno bubrezno oštećenje u jedinici intenzivne nege, 42. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2009:139-140.
  
  
  67. Ratković-Janković M, Miljković P, Pejčić Lj, Nikolić I, Lazarević D, Golubović E. Udruženost Nutcracker fenomena i nefrotskog sindroma kod šestogodišnje devojčice-prikaz slučaja. Prvi kongres pedijatara Srbije sa medjunarodnim učešćem, Zbornik sazetaka 2010: 213.
  
  
  68. Ratković-Janković M, Golubović E, Miljković P, Pejčic Lj, Nikolić I, Lazarević D. Procena stepena ugroženosti asfiktične novorođenčadi za razvoj akutnog oštećenja bubrega, 43. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2011: 148-149.
  
  
  69. Lazarević D, Vojinović J. Terapijski izazovi u sistemskoj sklerozi (SsC)- prikaz slučaja. Acta rheumatologica Belgradensia 2015; Vol 45 Suppl 1: 65-66.
  
  
  70. Jakovljević M, Lazarević D, Vojinović J. Hronična granulomatozna bolest kod ženskog pola-prikaz slučaja. 47. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2016:92.
  
  
  71. Lazarević D, Vojinović J, Sušić G, Bašić- Milošević J. Uticaj FokI polimorfizma gena za vitamin D receptor i TNFα-308 faktor nekroze tumora na težinu i ishod bolesti u juvenilnom idiopatskom artritisu (JIA). Acta rheumatologica Belgradensia 2017, Vol 47 Suppl 1: 56-57.
  
  
  72. Lazarević D, Ratković-Janković M, Jakovljević M, Vojinović J. Ishod dugogodišnjeg lečenja i bezbednost primene adalimumaba kod dece obolele od juvenilnog idiopatskog artritisa (JIA) sa artritisom. Acta rheumatologica Belgradensia 2021; Vol 51 Suppl 1: 193-194.
  
  
  73. Lazarević D, Vojinović J. Terapijski izazovi u sistemskoj sklerozi (SsC)- prikaz slučaja. 46. Pedijatrijski dani Srbije sa medjunarodnim ucescem, Zbornik radova 2015: 62.
  
  
  74. Jakovljevic M, Živković N, Lazarevic D, Vojinović J. Tuberkulozni meningitis-prikaz bolesnika. Treći kongres pedijatara Srbije, Zbornik sažetaka 2018:94.
  
  
  75. Мilenković J, Vojinović J, Milojković M, Lazarević D. Autoinflamatorne klinicke manifestacije kod nosioca mutacija i R202Q i polimorfizma MEFV gena u Srbiji. Treći godišnji kongres Udruženja za preventivnu pedijatriju Srbije (UPPS) sa međunarodnim učešćem, Zbornik apstrakata 2016:183.
  
  
  76. Nikolić I, Živanović S, Pejčić Lj, Ratković Janković M, Lazarević D, Milojević D. Atipični uzroci respiratornog distresa novorođenčadi. Peti kongres Udruženja za preventivnu pedijatriju Srbije (UPPS) sa međunarodnim učešćem, Zbornik apstrakata 2018:125.
  
  
  77. Lazarević D, Vojinović J. Hidradenitis suppurativa: Izazov postavljanja dijagnoze i lečenja kod adolescenata. Acta rheumatologica Belgradensia 2024, Vol 53 Suppl 1:81.